Neuropace Inc (NPCE) has a current Price-to-Book (P/B) ratio of 27.26. Compared to its 3-year average P/B ratio of 19.24, the current P/B ratio is approximately 41.70% higher. Relative to its 5-year average P/B ratio of 12.59, the current P/B ratio is about 116.54% higher. Neuropace Inc (NPCE) has a Forward Free Cash Flow (FCF) yield of approximately -3.28%. Compared to its 3-year average FCF yield of -10.89%, the current FCF yield is approximately -69.86% lower. Relative to its 5-year average FCF yield of -16.52%, the current FCF yield is about -80.13% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NPCE competitors is 2.54, providing a benchmark for relative valuation. Neuropace Inc Corp (NPCE.O) exhibits a P/S ratio of 5.23, which is 106.24% above the industry average. Given its robust revenue growth of 23.86%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NPCE increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NPCE in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NPCE currently overvalued or undervalued?

What is Neuropace Inc (NPCE) fair value?

NPCE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Neuropace Inc (NPCE) is between 4.74 to 15.98 according to relative valuation method.

How does NPCE's valuation metrics compare to the industry average?

The average P/S ratio for NPCE's competitors is 2.54, providing a benchmark for relative valuation. Neuropace Inc Corp (NPCE) exhibits a P/S ratio of 5.23, which is 106.24% above the industry average. Given its robust revenue growth of 23.86%, this premium appears sustainable.

What is the current P/B ratio for Neuropace Inc (NPCE) as of Mar 04 2026?

As of Mar 04 2026, Neuropace Inc (NPCE) has a P/B ratio of 27.26. This indicates that the market values NPCE at 27.26 times its book value.

What is the current FCF Yield for Neuropace Inc (NPCE) as of Mar 04 2026?

As of Mar 04 2026, Neuropace Inc (NPCE) has a FCF Yield of -3.28%. This means that for every dollar of Neuropace Inc's market capitalization, the company generates -3.28 cents in free cash flow.

What is the current Forward P/E ratio for Neuropace Inc (NPCE) as of Mar 04 2026?

As of Mar 04 2026, Neuropace Inc (NPCE) has a Forward P/E ratio of -22.27. This means the market is willing to pay $-22.27 for every dollar of Neuropace Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Neuropace Inc (NPCE) as of Mar 04 2026?

As of Mar 04 2026, Neuropace Inc (NPCE) has a Forward P/S ratio of 5.23. This means the market is valuing NPCE at $5.23 for every dollar of expected revenue over the next 12 months.

NPCE Valuation